Skip to main content
. Author manuscript; available in PMC: 2021 Apr 14.
Published in final edited form as: Med. 2021 Feb 23;2(4):395–410. doi: 10.1016/j.medj.2021.01.002

KEY RESOURCES TABLE.

REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
MCT1 Thermo Fisher Cat# MA5-18288; RRID: AB_2539662
MCT4 Santa Cruz Cat# 50329; RRID: AB_2189333
LDHA Cell Signaling Cat# C4B5; RRID: AB_2066887
LDHB Novus Cat# 3EP1565Y RRID: AB_1109158
B-Actin Sigma-Aldrich Cat# A3854; RRID: AB_262011
Tyrosine Hydroxylase Novus Cat# NB300-109; RRID: AB_10077691
Dopamine B-Hydroxylase Abcam Cat# ab209487
Homogentisate dioxygenase (HGD) Abcam Cat# ab225926
4-hydroxyphenylpyruvate dioxygenase (HPD) Abcam Cat# ab133515
Bacterial and Virus Strains
None
Biological Samples
Blood Samples This study N/A
Tumor Tissue This study N/A
Chemicals, Peptides, and Recombinant Proteins
[U-13C]Glucose Cambridge Isotope Laboratories Cat#CLM-1396-MPT-PK
Methoxyamine Sigma 226904
Methanol, LC/MS Grade Fisher Scientific A456-4
Acetonitrile, LC/MS Grade Fisher Scientific A9554
Pyridine Sigma Aldrich 270407
TBDMS Sigma Aldrich 394882
Critical Commercial Assays
None
Deposited Data
None
Experimental Models: Cell Lines
SK-N-AS ATCC Cat# CRL-2137 RRID:CVCL_1700
Experimental Models: Organisms/Strains
NSG female Mice UTSW Breeding Core NSG Mice
Oligonucleotides
None
Recombinant DNA
None
Software and Algorithms
Metaboanalyst McGill www.metaboanalyst.ca
The Cancer Genome Atlas NIH https://cancergenome.nih.gov
Therapeutically Applicable Research To Generate Effective Treatments NIH https://ocg.cancer.gov/programs/target/data-matrix